logo
episode-header-image
Dec 2021
38m 4s

COVID-19 Update: Omicron Variant

JAMA NETWORK
About this episode

Infectious disease experts Adam Lauring, MD, PhD, and Carlos del Rio, MD, join JAMA Associate Editor Preeti Malani, MD, MSJ, for a discussion of the newly emerged Omicron variant, the potential for a 2021-2022 "twindemic" with flu, and the latest COVID-19 clinical updates. Recorded December 1, 2021.

Related content:

Omicron Has Reached the US—Here’s What Infectious Disease Experts Know About the Variant

COVID-19 Update: Omicron Variant

Up next
Aug 13
Treatment of Complicated Staphylococcus aureus Bacteremia
Dalbavancin, a long-acting IV lipoglycopeptide, may be an option for the treatment of complicated Staphylococcus aureus bacteremia without requiring long-term IV access. Author Thomas L. Holland, MD, MSc, from Duke University School of Medicine discusses key points of the DOTS ra ... Show More
11m 35s
Aug 5
From the JAMA Network: Incidence and Nature of Antidepressant Discontinuation Symptoms
Interview with Sameer Jauhar, PhD, author of Incidence and Nature of Antidepressant Discontinuation Symptoms: A Systematic Review and Meta-Analysis. Hosted by John Torous, MD. Related Content: Incidence and Nature of Antidepressant Discontinuation Symptoms 
16m 29s
Jul 28
From the JAMA Network: GLP-1 Receptor Agonists in Idiopathic Intracranial Hypertension
Interview with Dennis J. Rivet II, MD, author of GLP-1 Receptor Agonists in Idiopathic Intracranial Hypertension. Hosted by Cynthia E. Armand, MD. Related Content: GLP-1 Receptor Agonists in Idiopathic Intracranial Hypertension 
22m 16s
Recommended Episodes
Feb 2023
Year 3 of COVID-19: Harsh Truths, Brutal Realities & Glimmers of Hope
Host: Darryl S. Chutka, M.D. [@chutkaMD] Guest: Greg A. Poland, M.D. [@drgregpoland] Severe acute respiratory syndrome coronavirus 2, also known as COVID-19, is a novel virus with a rapidly changing genotype. It’s responsible for over a million deaths so far. One of every 300 Ame ... Show More
31m 33s
Dec 2021
2021: The year of variants
In our first programme of the year, we gathered a group of scientific experts directly involved in analysing the structure and impact of the SARS- Cov-2 coronavirus. There were concerns over the emergence of two new variants, Alpha and Beta, especially whether these variants migh ... Show More
27m 23s
May 2022
Mayo Clinic Q&A: COVID-19 news update
This episode is shared from Mayo Clinic Q&A and was recorded in May 2022 Guest: Gregory A. Poland, M.D. (@drgregpoland) Host: Halena M. Gazelka, M.D. (@hmgazelkamd) The widespread availability of at-home COVID-19 tests have made it easier for people to know if they have the virus ... Show More
21m 12s
Dec 2021
What 2021 taught us about Covid
This year started with the focus on Covid-19 vaccine rollouts and ends with the emergence of a new coronavirus variant, Omicron. Ros Atkins looks at how the pandemic has evolved in 2021 and the challenges that lie ahead. 
10m 13s
Dec 2021
What do we need to know about the omicron variant?
Dr. Brian Goldman speaks with infectious diseases physician Dr. Zain Chagla about omicron, the new coronavirus variant of concern. 
21m 54s
Dec 2020
World-renowned COVID-19 expert Dr. Nicholas Christakis discusses the second wave, the vaccine, and the post-pandemic world
World-renowned COVID-19 expert Dr. Nicholas Christakis returns to the WHOOP Podcast to share everything you need to know about the second wave, vaccines, and how long it will take until things return to normal. Nicholas has dedicated his life’s work to understanding public health ... Show More
1h 2m
Dec 2021
What you need to know about the Omicron Variant - Çfarë duhet të dini për variantin Omicron
Scientists suspect the Omicron variant could be more contagious than the Delta variant of COVID-19 but patients are reporting mild symptoms like fatigue.Omicron has 86 mutations compared to Delta's 15 and it has infected those who are double vaccinated with experts racing to iden ... Show More
3m 50s
Jul 2022
Targetting OMICRON variants
Updated versions of coronavirus vaccines targeting the Omicron variant have recently been announced by Pfizer and Moderna. There's been an impressive turnaround time and yet still the virus has continued to mutate. 
7m 23s